CN102172385A - 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 - Google Patents
一种具有增强免疫力、降血糖和降血脂作用的中药制剂 Download PDFInfo
- Publication number
- CN102172385A CN102172385A CN2011100054135A CN201110005413A CN102172385A CN 102172385 A CN102172385 A CN 102172385A CN 2011100054135 A CN2011100054135 A CN 2011100054135A CN 201110005413 A CN201110005413 A CN 201110005413A CN 102172385 A CN102172385 A CN 102172385A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- fructus
- portions
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 47
- 210000004369 blood Anatomy 0.000 title claims abstract description 45
- 230000000694 effects Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 230000036039 immunity Effects 0.000 title claims abstract description 13
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 53
- 241001251068 Formica fusca Species 0.000 claims description 40
- 241000221377 Auricularia Species 0.000 claims description 20
- 241000222336 Ganoderma Species 0.000 claims description 19
- 241000218236 Cannabis Species 0.000 claims description 17
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 8
- 235000005903 Dioscorea Nutrition 0.000 claims description 6
- 241000234273 Dioscorea Species 0.000 claims description 6
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 6
- 235000004879 dioscorea Nutrition 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 abstract description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 abstract description 3
- 208000029078 coronary artery disease Diseases 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 230000037356 lipid metabolism Effects 0.000 abstract description 2
- 210000002381 plasma Anatomy 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 2
- 210000002700 urine Anatomy 0.000 abstract description 2
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 240000004308 marijuana Species 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 210000003734 kidney Anatomy 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 17
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 238000005325 percolation Methods 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 230000006837 decompression Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 241000203982 Macrotermes barneyi Species 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000866536 Odontotermes formosanus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- 241001620634 Roger Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110005413.5A CN102172385B (zh) | 2011-01-12 | 2011-01-12 | 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110005413.5A CN102172385B (zh) | 2011-01-12 | 2011-01-12 | 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102172385A true CN102172385A (zh) | 2011-09-07 |
CN102172385B CN102172385B (zh) | 2016-02-24 |
Family
ID=44515760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110005413.5A Expired - Fee Related CN102172385B (zh) | 2011-01-12 | 2011-01-12 | 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102172385B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103540513A (zh) * | 2013-11-06 | 2014-01-29 | 攀枝花学院 | 灵芝养颜组合物、酒剂及其制作方法和用途 |
CN103536819A (zh) * | 2013-11-06 | 2014-01-29 | 攀枝花学院 | 灵芝培元组合物、酒剂及其制作方法和用途 |
CN103585523A (zh) * | 2013-11-26 | 2014-02-19 | 淄博开发区亚大制药有限责任公司 | 一种治疗湿浊脾滞型高脂血症的中药制剂 |
CN103627600A (zh) * | 2013-11-21 | 2014-03-12 | 贵州鑫吾福酒业有限公司 | 一种玛咖养生酒及其制备方法 |
CN103828981A (zh) * | 2014-02-23 | 2014-06-04 | 廖少波 | 一种火麻茶 |
CN103859375A (zh) * | 2012-12-10 | 2014-06-18 | 天津红日药业股份有限公司 | 一种有助于增强免疫力的养生保健食品配方及其制备方法 |
CN108524908A (zh) * | 2018-07-20 | 2018-09-14 | 耿文保 | 治疗高血糖和糖尿病的中药组合物及其制备方法 |
CN110652540A (zh) * | 2019-10-31 | 2020-01-07 | 贵州省兴仁市中医院 | 一种食积型消渴病的治疗配方及其制备方法 |
CN114224977A (zh) * | 2022-01-12 | 2022-03-25 | 李望 | 一种用于调理三高的中药及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1107065A (zh) * | 1994-10-14 | 1995-08-23 | 张荣江 | 康力达酒的制作方法 |
CN1113778A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 老年病制剂 |
CN1166336A (zh) * | 1996-05-27 | 1997-12-03 | 陈即惠 | 蛇精生产方法 |
CN1686395A (zh) * | 2005-04-11 | 2005-10-26 | 王奉友 | 具有调节血压功能的保健品 |
-
2011
- 2011-01-12 CN CN201110005413.5A patent/CN102172385B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113778A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 老年病制剂 |
CN1107065A (zh) * | 1994-10-14 | 1995-08-23 | 张荣江 | 康力达酒的制作方法 |
CN1166336A (zh) * | 1996-05-27 | 1997-12-03 | 陈即惠 | 蛇精生产方法 |
CN1686395A (zh) * | 2005-04-11 | 2005-10-26 | 王奉友 | 具有调节血压功能的保健品 |
Non-Patent Citations (1)
Title |
---|
黄平 等: "糖尿病高血脂患者的生活方式健康教育及辨证施护", 《护理学报》 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103859375A (zh) * | 2012-12-10 | 2014-06-18 | 天津红日药业股份有限公司 | 一种有助于增强免疫力的养生保健食品配方及其制备方法 |
CN103540513A (zh) * | 2013-11-06 | 2014-01-29 | 攀枝花学院 | 灵芝养颜组合物、酒剂及其制作方法和用途 |
CN103536819A (zh) * | 2013-11-06 | 2014-01-29 | 攀枝花学院 | 灵芝培元组合物、酒剂及其制作方法和用途 |
CN103540513B (zh) * | 2013-11-06 | 2015-08-19 | 攀枝花学院 | 灵芝养颜组合物、酒剂及其制作方法和用途 |
CN103536819B (zh) * | 2013-11-06 | 2015-11-18 | 攀枝花学院 | 灵芝培元组合物、酒剂及其制作方法和用途 |
CN103627600A (zh) * | 2013-11-21 | 2014-03-12 | 贵州鑫吾福酒业有限公司 | 一种玛咖养生酒及其制备方法 |
CN103585523A (zh) * | 2013-11-26 | 2014-02-19 | 淄博开发区亚大制药有限责任公司 | 一种治疗湿浊脾滞型高脂血症的中药制剂 |
CN103585523B (zh) * | 2013-11-26 | 2016-08-17 | 淄博开发区亚大制药有限责任公司 | 一种治疗湿浊脾滞型高脂血症的中药制剂 |
CN103828981A (zh) * | 2014-02-23 | 2014-06-04 | 廖少波 | 一种火麻茶 |
CN108524908A (zh) * | 2018-07-20 | 2018-09-14 | 耿文保 | 治疗高血糖和糖尿病的中药组合物及其制备方法 |
CN110652540A (zh) * | 2019-10-31 | 2020-01-07 | 贵州省兴仁市中医院 | 一种食积型消渴病的治疗配方及其制备方法 |
CN114224977A (zh) * | 2022-01-12 | 2022-03-25 | 李望 | 一种用于调理三高的中药及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102172385B (zh) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102172385B (zh) | 一种具有增强免疫力、降血糖和降血脂作用的中药制剂 | |
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN1723926A (zh) | 一种中药药酒及其制法 | |
CN101513437A (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN102940801A (zh) | 一种治疗高血压的中药组合物 | |
CN108524814A (zh) | 一种用于降低血糖的中药组合物及其制备方法 | |
CN101053621B (zh) | 一种治疗肥胖症的中药组合物及其制备方法 | |
CN102161961B (zh) | 一种保健酒及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN101428113A (zh) | 一种治疗2型糖尿病的中药制剂及其制备方法 | |
CN103749818B (zh) | 一种黄精降糖降脂保健茶及其制备方法 | |
CN103550746A (zh) | 一种治疗心血管疾病的中药制剂 | |
CN101537160B (zh) | 一种排毒养颜保健品 | |
CN101884779A (zh) | 一种用于干预亚健康状态的黄精组合物及其制备方法 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN101085121A (zh) | 一种降血糖、降血脂的中药组合物及制法和应用 | |
CN100509025C (zh) | 一种治疗糖尿病的药物 | |
CN1685972A (zh) | 一种抗衰老保健食品 | |
CN101313994A (zh) | 用于治疗心房颤动中药胶囊 | |
CN103725587A (zh) | 黄精山楂醋及其生产方法 | |
CN104258359A (zh) | 一种用于治疗妊娠反应的中药组合物及其制剂的制备方法 | |
CN106389892A (zh) | 一种食疗粉及其制备方法 | |
CN106361976A (zh) | 一种安神助眠养颜复方制剂及其制备方法 | |
CN100398123C (zh) | 一种治疗肾脾两虚挟血瘀型糖尿病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DD01 | Delivery of document by public notice |
Addressee: Tu Chuanrong Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
C06 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Tu Chuanrong Document name: Notification of before Expiration of Request of Examination as to Substance |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Shan Dongjun Inventor before: Tu Chuanrong |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170427 Address after: 266000 Shandong province Shinan District of Qingdao City Nanhai Branch No. 5 16 C Patentee after: Qingdao Hairen Biotechnology Co., Ltd. Address before: 430074 Hubei Development Zone, East Lake, Optics Valley Venture Street, building 6, building 2, building Patentee before: Tu Chuanrong |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160224 Termination date: 20200112 |